Virax Biolabs VRAX
NASDAQ VRAX
$2.21 -0.03 (-1.36%)
As of: Oct 2, 2026 · 9:54 AM EDT

Virax Biolabs (VRAX) Debt Ratio (2021 - 2026)

Updated

Virax Biolabs' Debt Ratio came in at 0.00 for fiscal Q4 2026 (quarter ended Mar 31, 2026), down 32.3% from 0.01 a year earlier.

Analysis

Virax Biolabs (VRAX) Debt Ratio (2021 - 2026) Analysis & Trends

Going back to fiscal Q4 2021, Virax Biolabs' Debt Ratio data covers 8 quarters.

  • Going back by fiscal year, Debt Ratio was 0.01 in FY2025, 0.01 in FY2023 (-80.7%) and 0.08 in FY2022 (-18.7%).
  • The fiscal Q4 2026 figure represents the lowest quarterly Debt Ratio in data going back to fiscal Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 0.38
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 0.30
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 0.29
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn -
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 0.30
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 0.31
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 0.28
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 0.04
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 0.33
10 Virax Biolabs 866,746.23 -20.67 Mn - 0.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Sep 30, 2025 0.03
Mar 31, 2025 0.01
Sep 30, 2024 0.02
Mar 31, 2023 0.01
Sep 30, 2022 0.07
Mar 31, 2022 0.08
Mar 31, 2021 0.09
API Access

Virax Biolabs Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=VRAX&period=max&api_key=YOUR_API_KEY